ArticleBlood advances2023
Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.